Skip to main content
Clinical Trials/NL-OMON25426
NL-OMON25426
Completed
Not Applicable

A randomized double-blind placebo controlled trial to evaluate the safety and efficacy of the cholesterol absorption inhibitor, ezetimibe in a dosage of 10 mg, on plasma lipids, plant sterols and inflammatory markers in children with familial hypercholesterolemia.

Academic Medical Centre (AMC), Department of Vascular Medicine0 sites70 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Familial hypercholesterolemia
Sponsor
Academic Medical Centre (AMC), Department of Vascular Medicine
Enrollment
70
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

/A

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Academic Medical Centre (AMC), Department of Vascular Medicine

Eligibility Criteria

Inclusion Criteria

  • 1\. Males or females;
  • 2\. Aged 8\-14 years;

Exclusion Criteria

  • 1\. Homozygous familial hypercholesterolemia;
  • 2\. Diseases that cause a secondary increase in LDL\-C, such as diabetes mellitus, anorexia nervosa and renal, hepatic or thyroid disease;

Outcomes

Primary Outcomes

Not specified

Similar Trials